| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/07/2004 | EP1378517A1 Phosphoinositolglycan (PIG) binding protein from adipocytes |
| 01/07/2004 | EP1378516A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for HIV |
| 01/07/2004 | EP1378515A1 Peptides for inducing apoptosis in tumor cells |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377828A2 Methods of analysis and labeling of protein-protein interactions |
| 01/07/2004 | EP1377826A2 Opiate receptors |
| 01/07/2004 | EP1377680A2 Diagnosis and treatment of cancer: i |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377672A2 Vector constructs |
| 01/07/2004 | EP1377669A2 Production of apomictic seed |
| 01/07/2004 | EP1377667A2 Fusion proteins for specific treatment of cancer and auto-immune diseases |
| 01/07/2004 | EP1377666A2 Plant growth regulating genes, proteins and uses thereof |
| 01/07/2004 | EP1377665A2 Final segregation of male meiotic products in plants |
| 01/07/2004 | EP1377660A2 Vaccine against the nile fever virus |
| 01/07/2004 | EP1377611A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 01/07/2004 | EP1377610A2 Osteoprotegerin in milk |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377608A1 Insulin precursors and a process for their preparation |
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377606A1 Immunogenic cell surface proteins of helicobacter pylori |
| 01/07/2004 | EP1377605A2 Secreted streptococcus pneumoniae proteins |
| 01/07/2004 | EP1377604A2 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
| 01/07/2004 | EP1377603A1 Protein cluster v |
| 01/07/2004 | EP1377600A2 Methods of crystal optimisation |
| 01/07/2004 | EP1377597A2 Polynucleotide encoding a novel immunoglobulin superfamily member, apex4, and variants and splice variants thereof |
| 01/07/2004 | EP1377314A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 01/07/2004 | EP1377306A1 Serum albumin binding moieties |
| 01/07/2004 | EP1377304A2 A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 01/07/2004 | EP1377275A2 Vaccine for modulating between t1 and t2 immune responses |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1377157A2 Novel pesticidal toxins |
| 01/07/2004 | EP1034187B1 Growth-promoting proteins and peptides for kidney epithelial cells |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP1021556B1 Assay using marked microbial host cell strains |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0931092B1 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 01/07/2004 | EP0920326B1 Use of a bpi protein product as an antithrombotic agent |
| 01/07/2004 | EP0681480B1 Recognin vaccines |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466682A HCV antigen/antibody combination assay |
| 01/07/2004 | CN1466629A Modulation of abscisic acid signal transduction in plants |
| 01/07/2004 | CN1466628A A method of extracellular production of target proteins employing OmpF in e coli |
| 01/07/2004 | CN1466627A Method of estimating the genotype of fertility recovery locus to rice BT type male fertility cytoplasm |
| 01/07/2004 | CN1466626A Production process of subtilin surfactin |
| 01/07/2004 | CN1466466A Remedies for heart failure |
| 01/07/2004 | CN1465703A Synthesis, expression, preparation and application for human parathyroid hormone gene mutant |
| 01/07/2004 | CN1465702A Purifying and use for human vascular endothelial growth factor and granzyme B fusion protein |
| 01/07/2004 | CN1465594A Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465593A Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465592A Human Interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465591A Affinity functional zone cell anchoring factor for amino acid sequence arginine-glycine-aminosuccinic acid/cellulose and preparation method thereof |
| 01/07/2004 | CN1465590A Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof |
| 01/07/2004 | CN1465589A Gene recombination SARS virus coat protein S and preparation process thereof |
| 01/07/2004 | CN1465588A IL-6 antagonist pipetide and preparation process thereof |
| 01/07/2004 | CN1465587A Polypeptide-chondriosome carrier 18 and polynucleotide for colding said polypeptide |
| 01/07/2004 | CN1465396A Anti-tumor medicine |
| 01/07/2004 | CN1133979C Magnetizable device |
| 01/07/2004 | CN1133745C Method for immortalizing cells and immortalized cell |
| 01/07/2004 | CN1133652C Process for preparing collagen |
| 01/07/2004 | CN1133651C Snake venom enzyme nerve growth factor |
| 01/07/2004 | CN1133650C A method of identifying CFTP-binding compounds useful for activating chloride conductance in animal cells |
| 01/07/2004 | CN1133462C Methods and compositions for healing and repair of connective tissue attachment |
| 01/07/2004 | CN1133461C Application of tigroid spider toxic extract in preparnig analgesic |
| 01/06/2004 | US6675137 Method of data compression using principal components analysis |
| 01/06/2004 | US6675105 Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors |
| 01/06/2004 | US6673990 Biopesticides |
| 01/06/2004 | US6673916 Phospholipase inhibitors |
| 01/06/2004 | US6673915 Nucleic acid encoding monocyte chemotactic protein 4 |
| 01/06/2004 | US6673914 Human tumor-associated gene |
| 01/06/2004 | US6673911 Human polyhomeotic 2 (hph2) acts as an oncogene |
| 01/06/2004 | US6673910 Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics |
| 01/06/2004 | US6673909 Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy |
| 01/06/2004 | US6673904 Stem cell growth factor-like polypeptides |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673902 Cyclin D binding factor, and uses thereof |
| 01/06/2004 | US6673901 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 01/06/2004 | US6673900 Polypeptide hormone-phosphatonin |
| 01/06/2004 | US6673899 Protein for use treatment of diabetes |
| 01/06/2004 | US6673898 Estrone sulfate, dehydroepiandrosterone sulfate and/or ochratoxin a; genetically engineered mutant |
| 01/06/2004 | US6673897 Inhibitors of NF-κB Activation |
| 01/06/2004 | US6673896 Derivatives of soluble T-4 |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673894 Inhibitor of cell proliferation and methods of use thereof |
| 01/06/2004 | US6673893 Leukocyte derived growth factor 2 |
| 01/06/2004 | US6673776 Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human |
| 01/06/2004 | US6673771 Administering inhibitor of tumor necrosis factor related activator induced cytokine/receptor activator of nuclear factor kappa beta ligand, peptide having cyclic portion and exocyclic portions comprising tyrosine or phenylalanine |
| 01/06/2004 | US6673770 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 01/06/2004 | US6673769 Hybrid polypeptide |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673616 Cleavage of nucleic acid with hairpin motif using exo- or endonucleases; detection of bacterial or viral pathogens |
| 01/06/2004 | US6673615 Characterization of individual polymer molecules based on monomer-interface interactions |
| 01/06/2004 | US6673609 Diagnosing anemia |
| 01/06/2004 | US6673601 Plasmid; expression vector encodes glycoprotein |
| 01/06/2004 | US6673600 Transgenic C. elegans as a model organism for investigations on Alzheimer's disease |
| 01/06/2004 | US6673591 Increasing permissiveness of cell to viral replication by decreasing expression of interferon by making cell deficient in factor that regulates interferon expression in vivo |
| 01/06/2004 | US6673589 Exhibit alterations in at least one of the following properties relative to parent alpha-amylase: improved ph stability at ph 8-10.5, improved calcium ion stability at ph 8-10.5, increased specific activity at 10-60 degrees c |
| 01/06/2004 | US6673575 Use of cultured, recombinant eukaryotic cells in the production of glycoproteins for pharmaceutical use especially given the control in degree of glycosylation afforded by the procedure |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673572 Transfection of transcription or gene expression vectors in cells, then heating to improve recovery of myxoviruses, parainfluenza or respiratory syncytial virus; genetic engineering |